Search Results for

Showing 11 - 20 of 67 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Journals and Publications landing

    Journals and Publications ARVO Journals           Publications Grant The ARVO Publications Grant is available to authors who need funding assistance to publish in one of our three journals: Investigative Ophthalmology & Visual Science  (IOVS); Journal of Vision (JOV); and Translational Vision Science & Technology (TVST). This grant is supported by the ARVO Foundation and aligns with ARVO’s goal to capture the full spectrum of vision science in our family of journals. Several indivi

  3. China

    International Advocacy Toolkit: China Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When are

  4. Brazil

    International Advocacy Toolkit: Brazil Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When ar

  5. Japan

    International Advocacy Toolkit: Japan Organizing Questions Which organization/s are significant sources of research funding?  What does the normal science funding/policy decision-making process look like? Which patient advocacy groups, if any, are active in the area? Are there existing national/regional organizations that work towards improving research funding/policy? How do scientists currently contribute to the existing funding/policy-making/advocacy process, if at all?  When are

  6. MIN

    Members in the News Champalimaud MiN

  7. MIN

    Members in the News Champalimaud MiN

  8. OCT paper

    A peer-reviewed publication finds that vision research pays for itself

  9. OCT paper

    A peer-reviewed publication finds that vision research pays for itself